NEW YORK, NY / ACCESS Newswire / July 27, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Replimune Group, Inc. ("Replimune Group, Inc.") (NASDAQ:REPL) concerning possible violations of federal securities laws. On July 22, 2025, Replimune announced that it received a Complete Response Letter from the FDA rejecting its […]
NEW YORK, NY / ACCESS Newswire / July 27, 2025 / If you suffered a loss on your iRobot Corporation (NASDAQ:IRBT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/irobot-corporation-lawsuit-submission-form?prid=158346&wire=1&utm_campaign=23 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call
NEW YORK, NY / ACCESS Newswire / July 27, 2025 / If you suffered a loss on your RxSight, Inc. (NASDAQ:RXST) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/rxsight-inc-lawsuit-submission-form?prid=158345&wire=1&utm_campaign=25 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call
NEW YORK CITY, NY / ACCESS Newswire / July 27, 2025 / WHY:Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of securities of Luminar Technologies, Inc. (NASDAQ: LAZR) between March 20, 2025 and May 14, 2025, both dates inclusive (the "Class Period").
NEW YORK CITY, NY / ACCESS Newswire / July 27, 2025 / Pomerantz LLP announces that a class action lawsuit has been filed against Broadmark Realty Capital Inc. ("Broadmark" or the "Company") (NYSE:BRMK).�� Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail
NEW YORK, NY / ACCESS Newswire / July 27, 2025 / If you suffered a loss on your Hims & Hers Health, Inc. (NYSE:HIMS) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/hims-hers-health-inc-lawsuit-submission-form?prid=158344&wire=1&utm_campaign=28 or contact Joseph E. Levi, Esq. via email at
Washington, D.C., July 27, 2025 (GLOBE NEWSWIRE) — Rediscovering America's Strategic Core In a released presentation, renowned former national security advisor Jim Rickards warns that the next major shift in U.S. policy may come not from Wall Street or Washington–but from beneath the surface of federally controlled lands. “This story is not about real estate…
Former CIA Insider Highlights America's Buried Advantage in Online Presentation Jim Rickards uncovers overlooked U.S. law that may help reclaim control over key materials driving global innovation and national defense GlobeNewswire July 27, 2025 Washington, D.C., July 27, 2025 (GLOBE NEWSWIRE) — Rediscovering America's Strategic Core In a released presentation, renowned former national security advisor
(NYSE:HIMS), NEW YORK, July 27, 2025 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Hims & Hers Health, Inc. (NYSE: HIMS) between April 29, 2025 and June 23, 2025, both dates inclusive (the “Class Period”), of the important August 25, 2025 lead plaintiff deadline.
GLOBALLY RECOGNIZED ROSEN LAW FIRM Encourages Hims & Hers Health, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – HIMS GlobeNewswire July 27, 2025 NEW YORK, July 27, 2025 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Hims & Hers